Literature DB >> 31468199

Widefield optical coherence tomography angiography in diabetic retinopathy.

Rodolfo Mastropasqua1,2, Rossella D'Aloisio3, Luca Di Antonio4, Emanuele Erroi4, Enrico Borrelli5, Federica Evangelista4, Giada D'Onofrio4, Marta Di Nicola6, Giuseppe Di Martino7, Lisa Toto4.   

Abstract

AIMS: To evaluate superficial capillary plexus (SCP), deep capillary plexus (DCP) and choriocapillaris (CC) perfusion in macular and near/mid periphery regions in diabetic patients using widefield swept-source optical coherence tomography angiography (WSS-OCTA).
METHODS: Ninety-four diabetic patients (94 eyes) classified as diabetics without diabetic retinopathy (no DR) (25 eyes), mild DR (23 eyes), moderate/severe DR (26 eyes), proliferative DR (20 eyes) and a control group of 25 healthy subjects (25 eyes) were imaged with the WSS-OCTA system (PLEX Elite 9000, Carl Zeiss Meditec Inc., Dublin, CA, USA). Quantitative analysis was performed in the macular and peripheral regions. The main outcome measures were perfusion density (PD) and vessel length density of SCP, DCP and CC.
RESULTS: Peripheral retina (all sectors) showed lower SCP and DCP PD compared to the macular region (p  < 0.001). In diabetics without DR and DR in different stages, SCP and DCP PD significantly decreased at advancing stages of DR (p  < 0.001). At DCP level, central PD was significantly directly related to peripheral PD (superior, R = 0.682 and 0.479; temporal, R  = 0.918 and 0.554; inferior, R  = 0.711). A good sensitivity and an excellent specificity were found in terms of prediction of disease worsening, especially for central and temporal sectors in all plexuses and for all sectors both central and peripheral of DCP.
CONCLUSIONS: The widefield OCTA is useful for the study of central and peripheral retina in diabetic patients with or without diabetic retinopathy, assessing good correlation between central and peripheral retina.

Entities:  

Keywords:  Diabetic retinopathy; Perfusion density; Retinal periphery; Retinal vessel density; Widefield optical coherence tomography angiography

Mesh:

Year:  2019        PMID: 31468199     DOI: 10.1007/s00592-019-01410-w

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  10 in total

Review 1.  Widefield Optical Coherence Tomography Angiography in Diabetic Retinopathy.

Authors:  Alessia Amato; Francesco Nadin; Federico Borghesan; Maria Vittoria Cicinelli; Irini Chatziralli; Saena Sadiq; Rukhsana Mirza; Francesco Bandello
Journal:  J Diabetes Res       Date:  2020-11-24       Impact factor: 4.011

2.  Evaluation of the different thresholding strategies for quantifying choriocapillaris using optical coherence tomography angiography.

Authors:  Rita Laiginhas; Diogo Cabral; Manuel Falcão
Journal:  Quant Imaging Med Surg       Date:  2020-10

3.  Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus. Report 1: Diabetic Retinopathy.

Authors:  Marina Barraso; Aníbal Alé-Chilet; Teresa Hernández; Cristian Oliva; Irene Vinagre; Emilio Ortega; Marc Figueras-Roca; Anna Sala-Puigdollers; Cristina Esquinas; Enric Esmatjes; Alfredo Adán; Javier Zarranz-Ventura
Journal:  Transl Vis Sci Technol       Date:  2020-09-30       Impact factor: 3.283

4.  Effect of vessel enhancement filters on the repeatability of measurements obtained from widefield swept-source optical coherence tomography angiography.

Authors:  Jimmy Hong; Mengyuan Ke; Bingyao Tan; Amanda Lau; Damon Wong; Xinwen Yao; Xinyu Liu; Leopold Schmetterer; Jacqueline Chua
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

5.  Retinal vascular metrics difference by comparison of two image acquisition modes using a novel OCT angiography prototype.

Authors:  Luca Di Antonio; Pasquale Viggiano; Giada Ferro; Lisa Toto; Rossella D'Aloisio; Annamaria Porreca; Marta Di Nicola; Rodolfo Mastropasqua
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

6.  Recommendations for OCT Angiography Reporting in Retinal Vascular Disease: A Delphi Approach by International Experts.

Authors:  Marion R Munk; Amir H Kashani; Ramin Tadayoni; Jean-Francois Korobelnik; Sebastian Wolf; Francesco Pichi; Adrian Koh; Akihiro Ishibazawa; Alain Gaudric; Anat Loewenstein; Bruno Lumbroso; Daniela Ferrara; David Sarraf; David T Wong; Dimitra Skondra; Francisco J Rodriguez; Giovanni Staurenghi; Ian Pearce; Judy E Kim; K Bailey Freund; Maurizio Battaglia Parodi; Nadia K Waheed; Richard Rosen; Richard F Spaide; Shintaro Nakao; SriniVas Sadda; Stela Vujosevic; Tien Yin Wong; Toshinori Murata; Usha Chakravarthy; Yuichiro Ogura; Wolfgang Huf; Meng Tian
Journal:  Ophthalmol Retina       Date:  2022-02-22

7.  Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants.

Authors:  Rossella D'Aloisio; Luca Di Antonio; Lisa Toto; Marco Rispoli; Angelo Di Iorio; Giancarlo Delvecchio; Rodolfo Mastropasqua
Journal:  Medicina (Kaunas)       Date:  2022-08-12       Impact factor: 2.948

Review 8.  Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy.

Authors:  Inês Preguiça; André Alves; Sara Nunes; Pedro Gomes; Rosa Fernandes; Sofia D Viana; Flávio Reis
Journal:  Nutrients       Date:  2020-01-18       Impact factor: 5.717

9.  Widefield Swept Source OCTA in Retinitis Pigmentosa.

Authors:  Rodolfo Mastropasqua; Rossella D'Aloisio; Chiara De Nicola; Giada Ferro; Alfonso Senatore; Daniele Libertini; Guido Di Marzio; Marta Di Nicola; Giuseppe Di Martino; Luca Di Antonio; Lisa Toto
Journal:  Diagnostics (Basel)       Date:  2020-01-19

10.  A Custom-Made Semiautomatic Analysis of Retinal Nonperfusion Areas After Dexamethasone for Diabetic Macular Edema.

Authors:  Lisa Toto; Rossella D'Aloisio; Antonio Maria Chiarelli; Luca Di Antonio; Federica Evangelista; Giada D'Onofrio; Arcangelo Merla; Mariacristina Parravano; Guido Di Marzio; Rodolfo Mastropasqua
Journal:  Transl Vis Sci Technol       Date:  2020-06-11       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.